Amrita Centre for Nanoscience and Molecular Medicine, Amrita Institute of Medical Science, Cochin, 682 041, India.
Nanotechnology. 2010 Feb 5;21(5):055103. doi: 10.1088/0957-4484/21/5/055103. Epub 2009 Dec 21.
Molecular-receptor-targeted imaging of folate receptor positive oral carcinoma cells using folic-acid-conjugated fluorescent Au(25) nanoclusters (Au NCs) is reported. Highly fluorescent Au(25) clusters were synthesized by controlled reduction of Au(+) ions, stabilized in bovine serum albumin (BSA), using a green-chemical reducing agent, ascorbic acid (vitamin-C). For targeted-imaging-based detection of cancer cells, the clusters were conjugated with folic acid (FA) through amide linkage with the BSA shell. The bioconjugated clusters show excellent stability over a wide range of pH from 4 to 14 and fluorescence efficiency of approximately 5.7% at pH 7.4 in phosphate buffer saline (PBS), indicating effective protection of nanoclusters by serum albumin during the bioconjugation reaction and cell-cluster interaction. The nanoclusters were characterized for their physico-chemical properties, toxicity and cancer targeting efficacy in vitro. X-ray photoelectron spectroscopy (XPS) suggests binding energies correlating to metal Au 4f(7/2) approximately 83.97 eV and Au 4f(5/2) approximately 87.768 eV. Transmission electron microscopy and atomic force microscopy revealed the formation of individual nanoclusters of size approximately 1 nm and protein cluster aggregates of size approximately 8 nm. Photoluminescence studies show bright fluorescence with peak maximum at approximately 674 nm with the spectral profile covering the near-infrared (NIR) region, making it possible to image clusters at the 700-800 nm emission window where the tissue absorption of light is minimum. The cell viability and reactive oxygen toxicity studies indicate the non-toxic nature of the Au clusters up to relatively higher concentrations of 500 microg ml(-1). Receptor-targeted cancer detection using Au clusters is demonstrated on FR(+ve) oral squamous cell carcinoma (KB) and breast adenocarcinoma cell MCF-7, where the FA-conjugated Au(25) clusters were found internalized in significantly higher concentrations compared to the negative control cell lines. This study demonstrates the potential of using non-toxic fluorescent Au nanoclusters for the targeted imaging of cancer.
本文报道了叶酸受体阳性口腔癌细胞的分子受体靶向成像,方法是使用叶酸偶联的荧光金(Au)25 纳米团簇(Au NCs)。通过使用绿色化学还原剂抗坏血酸(维生素 C)还原 Au(+)离子,在牛血清白蛋白(BSA)中稳定,合成了高荧光 Au(25)团簇。为了基于靶向成像检测癌细胞,通过与 BSA 壳的酰胺键将簇与叶酸(FA)偶联。在 pH 值为 4 到 14 的宽范围内,生物共轭簇表现出极好的稳定性,并且在 pH 为 7.4 的磷酸盐缓冲盐水(PBS)中荧光效率约为 5.7%,这表明在生物共轭反应和细胞-簇相互作用期间血清白蛋白对纳米簇进行了有效的保护。对纳米簇的物理化学性质、体外毒性和癌症靶向功效进行了表征。X 射线光电子能谱(XPS)表明结合能与金属 Au 4f(7/2)约 83.97 eV 和 Au 4f(5/2)约 87.768 eV 相关。透射电子显微镜和原子力显微镜显示,形成了尺寸约为 1nm 的单个纳米簇和尺寸约为 8nm 的蛋白质簇聚集体。荧光发光研究表明,在大约 674nm 处具有最大荧光峰的明亮荧光,光谱轮廓覆盖近红外(NIR)区域,使得可以在光的组织吸收最小的 700-800nm 发射窗口处对纳米簇进行成像。细胞活力和活性氧毒性研究表明,Au 簇的非毒性性质高达相对较高的 500μgml(-1)浓度。在 FR(+ve)口腔鳞状细胞癌(KB)和乳腺癌腺癌 MCF-7 上进行的受体靶向癌症检测表明,与阴性对照细胞系相比,FA 偶联的 Au(25)簇被发现以更高的浓度被内化。这项研究证明了使用无毒荧光金纳米簇进行癌症靶向成像的潜力。